메뉴 건너뛰기




Volumn 25, Issue 10, 2011, Pages 1548-1554

Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia

Author keywords

acute leukemia; allele matching; unrelated donor transplantation

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; EUROPEAN GROUP OF BLOOD AND MARROW TRANSPLANTATION RISK SCORE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; T CELL DEPLETION; TRANSPLANTATION; TREATMENT OUTCOME; UNRELATED DONOR TRANSPLANTATION;

EID: 80054035323     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.123     Document Type: Article
Times cited : (16)

References (43)
  • 1
    • 40749159081 scopus 로고    scopus 로고
    • Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML)
    • DOI 10.1016/j.beha.2007.11.013, PII S1521692607001028
    • Appelbaum FR. Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML). Best Pract Res Clin Haematol 2008; 21: 85-92. (Pubitemid 351377515)
    • (2008) Best Practice and Research: Clinical Haematology , vol.21 , Issue.1 , pp. 85-92
    • Appelbaum, F.R.1
  • 2
    • 51549119954 scopus 로고    scopus 로고
    • Graft-versus-disease effect following allogeneic transplantation for acute leukaemia
    • Rowe JM. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia. Best Pract Res Clin Haematol 2008; 21: 485-502.
    • (2008) Best Pract Res Clin Haematol , vol.21 , pp. 485-502
    • Rowe, J.M.1
  • 3
    • 54049147312 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation in acute myeloid leukemia: A risk-adapted approach
    • Lodewyck T, Cornelissen JJ. Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach. Blood Rev 2008; 22: 293-302.
    • (2008) Blood Rev , vol.22 , pp. 293-302
    • Lodewyck, T.1    Cornelissen, J.J.2
  • 4
    • 58649087583 scopus 로고    scopus 로고
    • Optimal management of adults with ALL
    • Rowe JM. Optimal management of adults with ALL. Br J Haematol 2009; 144: 468-483.
    • (2009) Br J Haematol , vol.144 , pp. 468-483
    • Rowe, J.M.1
  • 5
    • 16844374525 scopus 로고    scopus 로고
    • Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: A metaanalysis
    • DOI 10.1002/cncr.20945
    • Yanada M, Matsuo K, Emi N, Naoe T. Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis. Cancer 2005; 103: 1652-1658. (Pubitemid 40490026)
    • (2005) Cancer , vol.103 , Issue.8 , pp. 1652-1658
    • Yanada, M.1    Matsuo, K.2    Emi, N.3    Naoe, T.4
  • 6
    • 67049164836 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: Systematic review and meta-analysis of prospective clinical trials
    • Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 2009; 301: 2349-2361.
    • (2009) JAMA , vol.301 , pp. 2349-2361
    • Koreth, J.1    Schlenk, R.2    Kopecky, K.J.3    Honda, S.4    Sierra, J.5    Djulbegovic, B.J.6
  • 8
    • 41349100708 scopus 로고    scopus 로고
    • In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: Final results of the International ALL Trial (MRC UKALLXII/ECOG E2993)
    • DOI 10.1182/blood-2007-10-116582
    • Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008; 111: 1827-1833. (Pubitemid 351451489)
    • (2008) Blood , vol.111 , Issue.4 , pp. 1827-1833
    • Goldstone, A.H.1    Richards, S.M.2    Lazarus, H.M.3    Tallman, M.S.4    Buck, G.5    Fielding, A.K.6    Burnett, A.K.7    Chopra, R.8    Wiernik, P.H.9    Foroni, L.10    Paietta, E.11    Litzow, M.R.12    Marks, D.I.13    Durrant, J.14    McMillan, A.15    Franklin, I.M.16    Luger, S.17    Ciobanu, N.18    Rowe, J.M.19
  • 10
    • 33847178661 scopus 로고    scopus 로고
    • Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remission
    • Appelbaum FR. Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remission. Best Pract Res Clin Haematol 2007; 20: 67-75.
    • (2007) Best Pract Res Clin Haematol , vol.20 , pp. 67-75
    • Appelbaum, F.R.1
  • 11
    • 33846585857 scopus 로고    scopus 로고
    • Role of consolidation therapy in the treatment of patients up to 60 years with high risk AML
    • Abstract 172
    • Krauter J, Heil G, Hoelzer D, Ottmann O, Martin H, Lübbert M et al. Role of consolidation therapy in the treatment of patients up to 60 years with high risk AML. Blood 2005; 106: abstract 172.
    • (2005) Blood , pp. 106
    • Krauter, J.1    Heil, G.2    Hoelzer, D.3    Ottmann, O.4    Martin, H.5    Lübbert, M.6
  • 13
    • 55949099856 scopus 로고    scopus 로고
    • Matched unrelated or matched sibling donors result in comparable survival after allogeneic stemcell transplantation in elderly patients with acute myeloid leukemia: A report from the cooperative german transplant study group
    • Schetelig J, Bornhäuser M, Schmid Ch, Hertenstein B, Schwerdtfeger R, Martin H et al. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stemcell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative german transplant study group. J Clin Oncol 2008; 26: 5183-5191.
    • (2008) J Clin Oncol , vol.26 , pp. 5183-5191
    • Schetelig, J.1    Bornhäuser, M.2    Schmid, Ch.3    Hertenstein, B.4    Schwerdtfeger, R.5    Martin, H.6
  • 14
    • 64849088683 scopus 로고    scopus 로고
    • Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemiafree survival compared with conventional chemotherapy in highrisk acute myeloid leukaemia patients in first complete remission
    • Basara N, Schulze A, Wedding U, Mohren M, Gerhardt A, Junghanss C et al. Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemiafree survival compared with conventional chemotherapy in highrisk acute myeloid leukaemia patients in first complete remission. Leukemia 2009; 23: 635-640.
    • (2009) Leukemia , vol.23 , pp. 635-640
    • Basara, N.1    Schulze, A.2    Wedding, U.3    Mohren, M.4    Gerhardt, A.5    Junghanss, C.6
  • 15
    • 77956931642 scopus 로고    scopus 로고
    • Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis
    • Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP et al. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood 2010; 116: 1839-1848.
    • (2010) Blood , vol.116 , pp. 1839-1848
    • Gupta, V.1    Tallman, M.S.2    He, W.3    Logan, B.R.4    Copelan, E.5    Gale, R.P.6
  • 16
    • 80054026973 scopus 로고    scopus 로고
    • Allogeneic hematopoietic cell transplantation in AML: Comparable results after matched or mismatched unrelated versus matched related transplantation
    • abstract 1199
    • Federmann B, Faul Ch, Vogel W, Kanz L, Bethge WA. Allogeneic hematopoietic cell transplantation in AML: Comparable results after matched or mismatched unrelated versus matched related transplantation. Blood 2009; 114: abstract 1199.
    • (2009) Blood , pp. 114
    • Federmann, B.1    Faul, Ch.2    Vogel, W.3    Kanz, L.4    Bethge, W.A.5
  • 17
    • 77954658470 scopus 로고    scopus 로고
    • Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission
    • Walter RB, Pagel JM, Gooley TA, Petersdorf EW, Sorror ML, Woolfrey AE et al. Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission. Leukemia 2010; 24: 1276-1282.
    • (2010) Leukemia , vol.24 , pp. 1276-1282
    • Walter, R.B.1    Pagel, J.M.2    Gooley, T.A.3    Petersdorf, E.W.4    Sorror, M.L.5    Woolfrey, A.E.6
  • 19
    • 70350090181 scopus 로고    scopus 로고
    • Risk score for outcome after allogeneic hematopoietic stem cell transplantation: A Retrospective Analysis
    • Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de Witte T et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a Retrospective Analysis. Cancer 2009; 115: 4715-4726.
    • (2009) Cancer , vol.115 , pp. 4715-4726
    • Gratwohl, A.1    Stern, M.2    Brand, R.3    Apperley, J.4    Baldomero, H.5    De Witte, T.6
  • 20
    • 23944440464 scopus 로고    scopus 로고
    • Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT
    • DOI 10.1182/blood-2005-05-2004
    • Sorror ML, Maris MB, Storb R, Storer BE, Stuart MJ, Hegenbart U et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912-2919. (Pubitemid 41510773)
    • (2005) Blood , vol.106 , Issue.8 , pp. 2912-2919
    • Sorror, M.L.1    Maris, M.B.2    Storb, R.3    Baron, F.4    Sandmaier, B.M.5    Maloney, D.G.6    Storer, B.7
  • 21
    • 39649115845 scopus 로고    scopus 로고
    • Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: Combined FHCRC and MDACC experiences
    • DOI 10.1182/blood-2007-06-096966
    • Sorror ML, Giralt S, Sandmaier BM, De Lima M, Shahjahan M, Maloney DG et al. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood 2007; 110: 4606-4613. (Pubitemid 351377830)
    • (2007) Blood , vol.110 , Issue.13 , pp. 4606-4613
    • Sorror, M.L.1    Giralt, S.2    Sandmaier, B.M.3    De Lima, M.4    Shahjahan, M.5    Maloney, D.G.6    Deeg, H.J.7    Appelbaum, F.R.8    Storer, B.9    Storb, R.10
  • 22
    • 49449102348 scopus 로고    scopus 로고
    • Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants
    • Majhail NS, Brunstein CG, McAvoy S, DeFor TE, Al-Hazzouri A, Setubal D et al. Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants. Biol Blood Marrow Transplant 2008; 14: 985-992.
    • (2008) Biol Blood Marrow Transplant , vol.14 , pp. 985-992
    • Majhail, N.S.1    Brunstein, C.G.2    McAvoy, S.3    Defor, T.E.4    Al-Hazzouri, A.5    Setubal, D.6
  • 23
    • 67349250764 scopus 로고    scopus 로고
    • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation
    • Farina L, Bruno B, Patriarca F, Spina F, Sorasio R, Morelli M et al. The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation. Leukemia 2009; 23: 1131-1138.
    • (2009) Leukemia , vol.23 , pp. 1131-1138
    • Farina, L.1    Bruno, B.2    Patriarca, F.3    Spina, F.4    Sorasio, R.5    Morelli, M.6
  • 26
    • 0018973048 scopus 로고
    • Chronic Graft-Versus-Host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients
    • DOI 10.1016/0002-9343(80)90380-0
    • Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A longterm clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217. (Pubitemid 10036817)
    • (1980) American Journal of Medicine , vol.69 , Issue.2 , pp. 204-217
    • Shulman, H.M.1    Sullivan, K.M.2    Weiden, P.L.3
  • 27
    • 0024694111 scopus 로고
    • Proposals for standardized reporting of results of bone marrow transplantation for leukaemia
    • Clift R, Goldman J, Gratwohl A, Horowitz M. Proposals for standardized reporting of results of bone marrow transplantation for leukaemia. Bone Marrow Transplant 1989; 4: 445-448.
    • (1989) Bone Marrow Transplant , vol.4 , pp. 445-448
    • Clift, R.1    Goldman, J.2    Gratwohl, A.3    Horowitz, M.4
  • 29
    • 77954574035 scopus 로고    scopus 로고
    • The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation
    • Shaw BE, Arguello R, Garcia-Sepulveda CA, Madrigal JA. The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation. Br J Haematol 2010; 150: 251-258.
    • (2010) Br J Haematol , vol.150 , pp. 251-258
    • Shaw, B.E.1    Arguello, R.2    Garcia-Sepulveda, C.A.3    Madrigal, J.A.4
  • 30
    • 61749084564 scopus 로고    scopus 로고
    • HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen
    • Kröger N, Zabelina T, Binder T, Ayuk F, Bacher U, Amtsfeld G et al. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen. Biol Blood Marrow Transplant 2009; 15: 454-462.
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 454-462
    • Kröger, N.1    Zabelina, T.2    Binder, T.3    Ayuk, F.4    Bacher, U.5    Amtsfeld, G.6
  • 31
    • 70749142248 scopus 로고    scopus 로고
    • HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: A study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry
    • Crocchiolo R, Ciceri F, Fleischhauer K, Oneto R, Bruno B, Pollichieni S et al. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry. Bone Marrow Transplant 2009; 44: 571-577.
    • (2009) Bone Marrow Transplant , vol.44 , pp. 571-577
    • Crocchiolo, R.1    Ciceri, F.2    Fleischhauer, K.3    Oneto, R.4    Bruno, B.5    Pollichieni, S.6
  • 32
    • 74249117356 scopus 로고    scopus 로고
    • Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles
    • Shaw BE, Mayor NP, Russell NH, Apperley JF, Clark RE, Cornish J et al. Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia 2010; 24: 58-65.
    • (2010) Leukemia , vol.24 , pp. 58-65
    • Shaw, B.E.1    Mayor, N.P.2    Russell, N.H.3    Apperley, J.F.4    Clark, R.E.5    Cornish, J.6
  • 35
    • 71749119885 scopus 로고    scopus 로고
    • Evaluation of human leukocyte antigen (HLA) Matching requirements for unrelated peripheral blood stem cell (PBSC) Transplantation
    • abstract 563
    • Woolfrey AE, Klein J, Haagenson MD, Spellman SR, Battiwalla M, Gajewski JL et al. Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation. Blood 2008; 112: abstract 563.
    • (2008) Blood , pp. 112
    • Woolfrey, A.E.1    Klein, J.2    Haagenson, M.D.3    Spellman, S.R.4    Battiwalla, M.5    Gajewski, J.L.6
  • 36
    • 0036625047 scopus 로고    scopus 로고
    • The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors
    • DOI 10.1182/blood.V99.11.4200
    • Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002; 99: 4200-4206. (Pubitemid 35332066)
    • (2002) Blood , vol.99 , Issue.11 , pp. 4200-4206
    • Morishima, Y.1    Sasazuki, T.2    Inoko, H.3    Juji, T.4    Akaza, T.5    Yamamoto, K.6    Ishikawa, Y.7    Kato, S.8    Sao, H.9    Sakamaki, H.10    Kawa, K.11    Hamajima, N.12    Asano, S.13    Kodera, Y.14
  • 38
    • 0032533228 scopus 로고    scopus 로고
    • Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class i and II alleles in the donor and recipient
    • Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Mickelson EM et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92: 3515-3520. (Pubitemid 28525174)
    • (1998) Blood , vol.92 , Issue.10 , pp. 3515-3520
    • Petersdorf, E.W.1    Gooley, T.A.2    Anasetti, C.3    Martin, P.J.4    Smith, A.G.5    Mickelson, E.M.6    Woolfrey, A.E.7    Hansen, J.A.8
  • 40
    • 0035892132 scopus 로고    scopus 로고
    • Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: The US National Marrow Donor Program Experience
    • Petersdorf EW, Kollman C, Hurley CK, Dupont B, Nademanee A, Begovich AB et al. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience. Blood 2001; 98: 2922-2929.
    • (2001) Blood , vol.98 , pp. 2922-2929
    • Petersdorf, E.W.1    Kollman, C.2    Hurley, C.K.3    Dupont, B.4    Nademanee, A.5    Begovich, A.B.6
  • 42
    • 33646042263 scopus 로고    scopus 로고
    • HLAC mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation
    • Ho VT, Kim HT, Liney D, Milford E, Gribben J, Cutler C et al. HLAC mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 37: 845-850.
    • (2006) Bone Marrow Transplant , vol.37 , pp. 845-850
    • Ho, V.T.1    Kim, H.T.2    Liney, D.3    Milford, E.4    Gribben, J.5    Cutler, C.6
  • 43
    • 48849095824 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: Weighing prognostic markers predicting relapse and risk factors for nonrelapse mortality
    • Meijer E, Cornelissen JJ. Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for nonrelapse mortality. Semin Oncol 2008; 35: 449-457.
    • (2008) Semin Oncol , vol.35 , pp. 449-457
    • Meijer, E.1    Cornelissen, J.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.